Directive 1992/25 - Wholesale distribution of medicinal products for human use

Please note

This page contains a limited version of this dossier in the EU Monitor.

1.

Current status

This directive was in effect from April 10, 1992 until December 17, 2001 and should have been implemented in national regulation on December 31, 1992 at the latest.

2.

Key information

official title

Council Directive 92/25/EEC of 31 March 1992 on the wholesale distribution of medicinal products for human use
 
Legal instrument Directive
Number legal act Directive 1992/25
Original proposal COM(1989)607
CELEX number i 31992L0025

3.

Key dates

Document 31-03-1992
Publication in Official Journal 30-04-1992; Special edition in Swedish: Chapter 13 Volume 022,OJ L 113, 30.4.1992,Special edition in Finnish: Chapter 13 Volume 022
Effect 10-04-1992; Entry into force Date notif.
End of validity 17-12-2001; Repealed by 32001L0083
Transposition 31-12-1992; At the latest See Art 11
Notification 10-04-1992

4.

Legislative text

Avis juridique important

|

5.

31992L0025

Council Directive 92/25/EEC of 31 March 1992 on the wholesale distribution of medicinal products for human use

Official Journal L 113 , 30/04/1992 P. 0001 - 0004

Finnish special edition: Chapter 13 Volume 22 P. 0029

Swedish special edition: Chapter 13 Volume 22 P. 0029

COUNCIL DIRECTIVE 92/25/EEC of 31 March 1992 on the wholesale distribution of medicinal products for human use

THE COUNCIL OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Economic Community, and in particular Article 100a thereof,

Having regard to the proposal from the Commission(1) ,

in cooperation with the European Parliament(2) ,

Having regard to the opinion of the Economic and Social Committee(3) ,

Whereas it is important to adopt measures with the aim of progressively establishing the internal market over a period expiring on 31 December 1992; whereas the internal market is to comprise an area without internal frontiers in which the free movement of goods, persons, services and capital is ensured;

Whereas the wholesale distribution of medicinal products is at present subject to different provisions in the various Member States; whereas many operations involving the wholesale distribution of medicinal products for human use may cover several Member States simultaneously;

Whereas it is necessary to exercise control over the entire chain of distribution of medicinal products, from their manufacture or import into the Community through to supply to the public, so as to guarantee that such products are stored, transported and handled in suitable conditions; whereas the requirements which must be adopted for this purpose will considerably facilitate the withdrawal of defective products from the market and allow more effective efforts against counterfeit products;

Whereas any person involved in the wholesale distribution of medicinal products should be in possession of a special authorization; whereas pharmacists and persons authorized to supply medicinal products directly to the public, and who confine themselves to this activity, should be exempt from obtaining this authorization; whereas it is however necessary, in order to control the complete chain of distribution of medicinal products, that pharmacists and persons authorized to supply medicinal products to the public keep records showing transactions in products received;

Whereas authorization must be subject to certain essential conditions and it is the responsibility of the Member State concerned to ensure that such conditions are met; whereas each Member State must recognize authorizations granted by other Member States;

Whereas certain Member States impose on wholesalers who supply medicinal products to pharmacists and on persons authorized to supply medicinal products to the public certain public service obligations; whereas those Member States must be able to continue to impose those obligations on wholesalers established within their territory; whereas they must also be able to impose them on wholesalers in other Member States on condition that they do not impose any obligation more stringent than those which they impose on their own wholesalers and provided that such obligations may be regarded as warranted on grounds of public health protection and are proportionate in relation to the objective of such protection,

HAS ADOPTED THIS DIRECTIVE:

Article 1

  • 1. 
    This Directive covers the wholesale distribution in the Community of medicinal products for human use to which Chapters II to V of Council Directive 65/65/EEC of 26 January 1965 on the approximation of provisions laid down by law, regulation or administrative action relating to medicinal products(4) apply.
  • 2. 
    For the purposes of this Directive:
  • wholesale distribution of medicinal products shall mean all activities consisting of procuring, holding, supplying or exporting medicinal products, apart...

More

This text has been adopted from EUR-Lex.

6.

Original proposal

 

7.

Sources and disclaimer

For further information you may want to consult the following sources that have been used to compile this dossier:

This dossier is compiled each night drawing from aforementioned sources through automated processes. We have invested a great deal in optimising the programming underlying these processes. However, we cannot guarantee the sources we draw our information from nor the resulting dossier are without fault.

 

8.

Full version

This page is also available in a full version containing the legal context, de Europese rechtsgrond, other dossiers related to the dossier at hand and the related cases of the European Court of Justice.

The full version is available for registered users of the EU Monitor by ANP and PDC Informatie Architectuur.

9.

EU Monitor

The EU Monitor enables its users to keep track of the European process of lawmaking, focusing on the relevant dossiers. It automatically signals developments in your chosen topics of interest. Apologies to unregistered users, we can no longer add new users.This service will discontinue in the near future.